Nutrien (NTR) PT Raised to $66.00

Nutrien (NYSE:NTR) had its price target hoisted by equities research analysts at Macquarie from $59.00 to $66.00 in a research note issued to investors on Friday, Stock Target Advisor reports. The brokerage currently has an “outperform” rating on the stock. Macquarie’s price target would suggest a potential upside of 22.06% from the company’s current price.

NTR has been the subject of a number of other research reports. Raymond James boosted their price target on Nutrien from $65.00 to $67.00 and gave the company a “strong-buy” rating in a research note on Friday, August 3rd. Stephens set a $64.00 price target on Nutrien and gave the company a “buy” rating in a research note on Monday, August 6th. Zacks Investment Research downgraded Nutrien from a “buy” rating to a “hold” rating in a research note on Wednesday, August 1st. Royal Bank of Canada set a $63.00 price target on Nutrien and gave the company a “buy” rating in a research note on Thursday, August 2nd. Finally, Scotiabank downgraded Nutrien from a “focus list” rating to an “outperform” rating in a research note on Thursday, September 20th. One analyst has rated the stock with a sell rating, seven have given a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $62.12.

NTR stock opened at $54.07 on Friday. Nutrien has a 52 week low of $40.41 and a 52 week high of $58.99.

Nutrien (NYSE:NTR) last posted its quarterly earnings results on Wednesday, August 1st. The company reported $1.48 EPS for the quarter, beating the Zacks’ consensus estimate of $1.40 by $0.08. The business had revenue of $8.15 billion during the quarter, compared to the consensus estimate of $7.70 billion. Nutrien had a return on equity of 10.27% and a net margin of 9.83%. The company’s revenue for the quarter was up 10.8% on a year-over-year basis. As a group, equities research analysts anticipate that Nutrien will post 2.55 EPS for the current fiscal year.

A number of hedge funds and other institutional investors have recently modified their holdings of NTR. Whittier Trust Co. raised its stake in Nutrien by 253.2% during the second quarter. Whittier Trust Co. now owns 2,790 shares of the company’s stock worth $152,000 after acquiring an additional 2,000 shares in the last quarter. Bessemer Group Inc. acquired a new position in shares of Nutrien in the second quarter valued at approximately $161,000. Huntington National Bank acquired a new position in shares of Nutrien in the second quarter valued at approximately $199,000. Lapides Asset Management LLC acquired a new position in shares of Nutrien in the second quarter valued at approximately $200,000. Finally, DeDora Capital Inc. acquired a new position in shares of Nutrien in the second quarter valued at approximately $203,000. 66.34% of the stock is owned by hedge funds and other institutional investors.

Nutrien Company Profile

Nutrien Ltd. produces and markets crop nutrients worldwide. The company offers potash, nitrogen, phosphate, and solid and liquid phosphate fertilizers; and phosphate feed, ammonium sulfate, and industrial acid products. It also retails seeds, crop protection and crop nutrient products, merchandise products, and agronomic services through operating 1,500 retail locations.

Further Reading: Can individual investors take part in an IPO?

Stock Target Advisor

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply